Zhang, Lijing
Xie, Xuping http://orcid.org/0000-0003-0918-016X
Luo, Hannan
Qian, Runtong
Yang, Yang
Yu, Hongtao http://orcid.org/0000-0002-8861-049X
Huang, Jing http://orcid.org/0000-0001-9639-2907
Shi, Pei-Yong http://orcid.org/0000-0001-5553-1616
Article History
Received: 6 November 2023
Accepted: 27 March 2024
First Online: 9 April 2024
Conflict of interest
: L.Z., H.Y., J.H., and Q.H. are co-inventors of patents that cover the 3CLpro inhibitor WU-04 in this study. H.Y., J.H., and Q.H. are founders of Westlake Pharmaceuticals (Hangzhou) Co., Ltd. and members of its scientific advisory board. Other authors declare no competing interests.